Grinchenko T. Peculiarities of the mild and moderate essential hypertension (EH) and unstable angina pectoris (UAP) duration by the influence enalaprila maleas.

103 patients with EH I-III stages and with whole duration UAP and EH before - after treatment. Scientifically to train necesserity using enalaprila maleas as monotherapy patientts with mild and moderate EH and by constellation with UAP on different stages of development hypertensive heart (HH). Ambulatory blood pressure monitoring (ABPM) (Meditech/02 m), echo-, dopplerechocardiography (Ultramark-9), electrocardiography (6 NEK 4), bicycleergometry (Ritm VE 05). Superiority inhibitor angiotensin-converting-enzyme (IACE) by the diuretics for antihypertensive efficacy and influence on condition HH; absence antiischemic and antianginal effects of IACE. Were determined charts of therapy patients with EH I-III stages, UAP and EH: were trained criteria improvement antihypertensive efficacy enalaprila and necesserity control's by the treatment by ABPM. Charts of therapy patients with EH I-III stages, UAP and EH, in whole - 10 act's of using. Antihypertensive efficacy of enalaprila during the treatment patientsw ith EH - 75,9%, in combination with furosemid - 95,9%. Cardiology and therapeutic department's of hospital, ambulatory.